3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid

C55H76N16O12S2 — CID 130410794

IUPAC3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid
SMILESCCCCC(C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC2CN=CN2)NC(=O)[C@H](CCC(=O)O)NC1=O)N1C(=O)N[C@@H](C(C)C)C1=O
InChIInChI=1S/C55H76N16O12S2/c1-4-5-17-42(71-53(82)44(29(2)3)70-55(71)83)52(81)69-41-27-85-84-26-40(45(56)74)68-49(78)38(22-31-24-61-34-15-10-9-14-33(31)34)66-46(75)35(16-11-20-60-54(57)58)63-48(77)37(21-30-12-7-6-8-13-30)65-50(79)39(23-32-25-59-28-62-32)67-47(76)36(64-51(41)80)18-19-43(72)73/h6-10,12-15,24,28-29,32,35-42,44,61H,4-5,11,16-23,25-27H2,1-3H3,(H2,56,74)(H,59,62)(H,63,77)(H,64,80)(H,65,79)(H,66,75)(H,67,76)(H,68,78)(H,69,81)(H,70,83)(H,72,73)(H4,57,58,60)/t32?,35-,36-,37+,38-,39-,40-,41-,42?,44-/m0/s1
InChIKeyAPZLAISDOWEROZ-PMCHQBOKSA-N
MW1217.45 g/mol
LogP-1.33
Rot. Bonds21

About 3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid

3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid (PubChem CID 130410794) has the molecular formula C55H76N16O12S2 and a molecular weight of 1217.45 g/mol. Its IUPAC name is 3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid.

Molecular Properties

Compound Name3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid
PubChem CID130410794
Molecular FormulaC55H76N16O12S2
Molecular Weight1217.45 g/mol
Exact Mass1216.53
IUPAC Name3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid
SMILESCCCCC(C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC2CN=CN2)NC(=O)[C@H](CCC(=O)O)NC1=O)N1C(=O)N[C@@H](C(C)C)C1=O
InChIInChI=1S/C55H76N16O12S2/c1-4-5-17-42(71-53(82)44(29(2)3)70-55(71)83)52(81)69-41-27-85-84-26-40(45(56)74)68-49(78)38(22-31-24-61-34-15-10-9-14-33(31)34)66-46(75)35(16-11-20-60-54(57)58)63-48(77)37(21-30-12-7-6-8-13-30)65-50(79)39(23-32-25-59-28-62-32)67-47(76)36(64-51(41)80)18-19-43(72)73/h6-10,12-15,24,28-29,32,35-42,44,61H,4-5,11,16-23,25-27H2,1-3H3,(H2,56,74)(H,59,62)(H,63,77)(H,64,80)(H,65,79)(H,66,75)(H,67,76)(H,68,78)(H,69,81)(H,70,83)(H,72,73)(H4,57,58,60)/t32?,35-,36-,37+,38-,39-,40-,41-,42?,44-/m0/s1
InChIKeyAPZLAISDOWEROZ-PMCHQBOKSA-N
XLogP-1.33
TPSA438.08 Ų
H-Bond Donors14
H-Bond Acceptors16
Rotatable Bonds21
Heavy Atoms85
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001217.45
LogP ≤ 5-1.33
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'disulphide', 'substructure': 'N/A'}, {'alert_name': 'hydantoin', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid?
The IUPAC name of 3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid (CID 130410794) is 3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid.
What is the SMILES notation for 3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid?
The canonical SMILES for 3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid is CCCCC(C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC2CN=CN2)NC(=O)[C@H](CCC(=O)O)NC1=O)N1C(=O)N[C@@H](C(C)C)C1=O.
What is the InChIKey of 3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid?
The InChIKey is APZLAISDOWEROZ-PMCHQBOKSA-N. The full InChI is InChI=1S/C55H76N16O12S2/c1-4-5-17-42(71-53(82)44(29(2)3)70-55(71)83)52(81)69-41-27-85-84-26-40(45(56)74)68-49(78)38(22-31-24-61-34-15-10-9-14-33(31)34)66-46(75)35(16-11-20-60-54(57)58)63-48(77)37(21-30-12-7-6-8-13-30)65-50(79)39(23-32-25-59-28-62-32)67-47(76)36(64-51(41)80)18-19-43(72)73/h6-10,12-15,24,28-29,32,35-42,44,61H,4-5,11,16-23,25-27H2,1-3H3,(H2,56,74)(H,59,62)(H,63,77)(H,64,80)(H,65,79)(H,66,75)(H,67,76)(H,68,78)(H,69,81)(H,70,83)(H,72,73)(H4,57,58,60)/t32?,35-,36-,37+,38-,39-,40-,41-,42?,44-/m0/s1.
What are the key properties of 3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid?
3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid has a molecular weight of 1217.45 g/mol, XLogP of -1.33, 21 rotatable bonds, 14 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(4R,7S,10S,13R,16S,19S,22R)-13-benzyl-4-carbamoyl-10-[3-(diaminomethylideneamino)propyl]-16-(4,5-dihydro-1H-imidazol-5-ylmethyl)-22-[[(2S)-2-[(4S)-2,5-dioxo-4-propan-2-ylimidazolidin-1-yl]hexanoyl]amino]-7-(1H-indol-3-ylmethyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricos-19-yl]propanoic acid is sourced from PubChem (CID 130410794), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).